Floatz logo

Losartan

Ascites

Odense University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Ascites cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Centro Medico Issemym
Phase 4BBB
Tolvaptan
Konkuk University Medical Center
Phase 4BBB
FUROSEMIDE
University of Palermo
Phase 4BB
Rifaximin
Centre Hospitalier Universitaire de Besancon
Phase 4BB
CARVEDILOL
Asian Institute Of Medical Sciences
Phase 4BB

View all 36 →

Same molecule, other indications

Losartan is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
Cognitively Normal Older AdultsDormant
BB
Indicative ·
66 / 100
View asset →
Subjective Cognitive DeclineDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →